A Xenopus oocyte expression system was used to examine how glucose transporters (GLUT 2 and GLUT 3) and glucokinase (GK) activity affect glucose utilization. Uninjected oocytes had low rates of both glucose transport and phosphorylation; expression of GLUT 2 or GLUT 3 increased glucose phosphorylation -20-fold by a low K., endogenous hexokinase at glucose concentrations -1 mM, but not at higher glucose concentrations. Coexpression of functional GK isoforms with GLUT 2 or 3 increased glucose utilization approximately an additional two-to threefold primarily at the physiologic glucose concentrations of 5-20 mM. The Km for glucose of both the hepatic and beta cell isoforms of GK, determined in situ, was -5-10 mM when coexpressed with either GLUT 2 or GLUT 3. The increase in glucose utilization by coexpression of GLUT 3 and GK was dependent upon glucose phosphorylation since two missense GK mutations linked with maturity-onset diabetes, 182:Val--Met and 228:Thr-+Met, did not increase glucose utilization despite accumulation of both a similar amount of immunoreactive GK protein and glucose inside the cell. Coexpression of a mutant GK and a normal GK isoform did not interfere with the function of the normal GK enzyme. Since the coexpression of GK and a glucose transporter in oocytes resembles conditions in the hepatocyte and pancreatic beta cell, these results indicate that increases in glucose utilization at glucose concentrations > 1 mM depend upon both a functional glucose transporter and GK. (J. Clin. Invest. 1994Invest. . 94:1373Invest. -1382
Introduction
The initial step in glucose utilization in mammalian cells is the movement of glucose across the plasma membrane by diffusion This is followed by the phosphorylation of glucose on the sixth carbon position by a family of hexokinases (HK types I-IV) (1, 2). The five different mammalian glucose transporters and four different hexokinases that have been identified constitute two different gene families whose members display distinctive tissue distributions and kinetic properties. Although distinct processes, glucose transport and phosphorylation are functionally paired since the kinetic properties of the specific glucose transporter or hexokinase present in a given cell may influence the overall rate of glucose utilization. The relative contribution of either process to glucose utilization may vary from tissue to tissue. For instance, in the pancreatic beta cell and hepatocyte, the rate of glucose utilization is determined by the amount of glucokinase (HK IV), since the Vma,, of glucose phosphorylation is less than that of glucose transport (3) . In contrast, the rate of glucose utilization in fat appears to be determined largely at the level of glucose transport, as insulin stimulation of transport increases glucose phosphorylation by the hexokinase present in adipocytes (4) .
The functional pairing of glucose transport and phosphorylation may explain why certain glucose transporters and hexokinases are coexpressed in a tissue-specific pattern and why high affinity transporters are coexpressed with high affinity hexokinases and low affinity transporters with low affinity hexokinases. For example, the pancreatic beta cell and the liver coexpress the low affinity GLUT 2 and the low affinity glucokinase (HK IV), while skeletal muscle and fat coexpress the high affinity GLUT 1/GLUT 4 and the high affinity HK II, and the brain coexpresses the high affinity GLUT 1/GLUT 3 and the high affinity HK I (1, 5) . Although the functional pairing of glucose transport and phosphorylation may be important in determining the rate of glucose utilization, it has been difficult to independently ascertain the relative contribution of each process to glucose utilization in different mammalian cells. Most studies have focused on either transport or phosphorylation in isolation, and it has not been possible to examine the interaction of particular transporters and hexokinases.
In this study we examined the functional importance of glucose transporter and glucokinase activity on glucose utilization in a Xenopus oocyte expression system. This is an important issue since glucokinase (GK) is thought to determine glucose usage by both the pancreatic beta cell and the hepatocyte (3). Glucose-stimulated insulin secretion by the beta cell correlates with the rate of glucose utilization, and the rate-limiting determinant in this process is GK (3, 6) . Moreover, GK gene mutations have been associated recently with a familial form of early onset non-insulin-dependent diabetes mellitus known as maturity-onset diabetes of the young (MODY) that is characterized by the development of hyperglycemia early in life, disease transmission in an autosomal dominant manner, and reduced glucose-stimulated insulin secretion (7) (8) (9) (10) (11) (12) (13) . Gidh-Jain et al. (14) have shown that most diabetes-linked GK mutants, when expressed in bacteria, have either a reduced V,. or affinity for glucose, thus suggesting that the diabetes in these pedigrees is due to the altered kinetic properties of the enzyme. We have tested this hypothesis further by examining the effect of GK mutations on glucose utilization and GK protein stability in an intact eukaryotic cell. In addition, we have examined the effect of coexpressing a mutant GK protein in the presence of a normal GK isoform to determine whether the autosomal dominant mode of inheritance of diabetes in pedigrees with GK gene mutations is solely due to a gene dosage phenomenon. [2-3H] glucose and unlabeled glucose at concentrations of 0.1-40 mM. After a 3-h incubation with glucose, a 100-y1l aliquot of the oocyte medium was fixed with isopropanol and applied to a 0.2 ml Dowex AG1-X8 column (converted to the borate form by extensive washing with 1 N NaOH followed by 0.3 M boric acid) to separate the 3H20 from the [2-3H]glucose (19). Tritiated water was eluted with two 0.5-ml aliquots of water, and [2-3H]glucose was eluted with two 0.5-ml additions of 1 N HCl. The amount of 3H20 was quantitated by liquid scintillation counting. The rate of 3H20 production in this assay was linear for up to 20 h (data not shown).
Methods
To measure the intracellular glucose concentration, oocytes were incubated with [2-3H]glucose in 1-20 mM glucose for 6 h and then quickly rinsed three times in OR medium (21) . The oocytes were then transferred to a scintillation vial containing fresh OR and incubated for 24 h. After the 24-h incubation period, the oocytes were removed from the OR medium, and the amount of radioactivity remaining in the OR medium was taken to represent the intracellular glucose at the end of the incubation with the various glucose concentrations. The rationale for this assumption is as follows: since the amount of tritiated water and tritiated metabolites retained in the oocyte is extremely low (not shown), and since the only product of [2-3H] glucose metabolism in the oocytes is 3H20, the intracellular glucose at the end of the initial 6-h incubation will be the sum of 3H20 and [2-3H]glucose (representing efflux of unmetabolized glucose from the oocyte). The intracellular glucose space was taken to be the same as that of 3-O-methyl-D-glucose, which was determined in separate experiments by measuring the distri- To measure GK activity in a broken cell assay, groups of one to seven oocytes, which had been coinjected with GLUT 3 and GK, were homogenized in 100 ,A/oocyte of 50 mM triethanolamine (TEA) (pH 7.3), 100 mM KCI, 1 mM DTT, 5% glycerol, 1 mM EGTA, 1 mM EDTA, 1 mM PMSF, 1 Itg/ml pepstatin A, 1 sg/ml leupeptin, 0.02% Na azide, 0.5% Triton X-100 (pH 7.3), and 20 jl/oocyte of 25% polyethylene glycol. The homogenate was placed on ice for 15 (Fig. 1 A) , and the utilization of glucose, measured by the production of 3H20 (Fig. 1 B) . The rate of glucose uptake and utilization plateaued with 5 ng of RNA per oocyte and did not increase significantly with the injection of up to 20 ng of RNA. The increase in 3H20 production by expression of GLUT 2 or GLUT 3 occurred primarily at glucose concentrations -1 mM (Fig.  2 A) . These results indicate that glucose transport is the ratelimiting step in glucose utilization in uninjected or sham-injected oocytes. Coinjection of RNA encoding the hepatic or islet GK isoform and GLUT 2 or GLUT 3 RNA resulted in a two-to threefold further increase in the rate of glucose utilization, primarily at glucose concentrations > 1 mM (Fig. 2 A-C) . Expression of GK alone (no glucose transporter) did not increase glucose transport or glucose utilization (data not shown). Measurements of intracellular and extracellular glucose in oocytes injected with glucose transporter RNA only, or oocytes injected with both transporter and GK RNA, were identical (Fig. 3 A) . Glucose accumulation (measured 1 and 30 min after addition of 3-0-[3H]-methyl-D-glucose) was not affected by the coexpression of GK and GLUT 3 (Fig. 3 B) . Thus, for all calculations shown in Figs. 2 and 4 , the glucose concentration plotted on the x-axis is the extracellular glucose concentration since intracellular and extracellular glucose concentrations are equal. Similar HK and GK activities were obtained with either GLUT 2 or GLUT 3 ( Fig. 1 and data not shown) . These results indicate that in GLUT 2-or GLUT 3-expressing oocytes glucose phosphorylation is the rate-limiting step in glucose utilization.
Analysis ofGK activity in Xenopus oocytes. When examined in the oocyte system, the in situ kinetic properties of rat liver GK and human islet GK are similar to those found in normal islets or liver (references 24 and 25 and Table I ). In the oocyte system, the rat liver GK and human islet GK were quite similar in their affinity for glucose (5.75 mM compared with 8.3 mM), and under conditions of maximal GK expression in the oocytes the V,,. of the rat liver GK was slightly greater than that of the human islet GK ( Table I ). The Km values for GK expressed in the oocyte system are similar to those determined by in situ measurements of GK in hepatocytes and islets and to those obtained with recombinant GK produced by prokaryotic and eukaryotic expression (24, 25) . Our results differ from those reported previously in which the rat islet GK isoform had a greater V. than the rat hepatic GK isoform when expressed in either a eukaryotic or prokaryotic expression system (25) . Whether these small differences in Km and V,, relate to minor amino acid differences in the amino terminus of the hepatic and islet forms of GK, to species differences, or to differences in translational efficiency between the islet and liver GK RNA is unknown. Xenopus oocytes possess an endogenous HK activity with a much lower Km (0.51 mM) for glucose than GK (Fig. 2  C and Table I ).
In addition to the in situ measurement of the GK Km for glucose and V,., the oocytes were homogenized to further study GK enzymatic activity in a broken cell assay. Under these conditions the Km of the human islet GK was similar while the V.. was -13 times higher in the homogenate than in the intact oocytes ( Fig. 4 and Table I ). A similar observation was noted when HK H was expressed in the oocyte system in that HK H activity was 5-10 times greater in the oocyte homogenate than in the intact oocyte assay (data not shown). The apparent increase in HK or GK is not due to activation of the enzyme during homogenization since purified HK H is not activated by the homogenization procedure (data not shown). A similar difference between HK activity in intact pancreatic islets versus pancreatic islet homogenate has been noted previously (26, 27) . The reason for the greater amount of GK activity in the oocyte homogenate compared with the intact oocyte assay is unclear, but it is possible that there is compartmentalization of GK in intact oocytes to a location that is not accessible to glucose and that homogenization releases the enzyme. Compartmentalization of glucose transporters has been noted in the oocyte system with the majority of glucose transporters located intracellularly and only a small percentage in the plasma membrane (28, 29) . An alternative possibility is that homogenization removes GK or HK II from inhibition by an intracellular regulator such as glucose-6-phosphate. However, since GK is not inhibited by glucose-6-phosphate, this seems less likely.
Analysis of GK missense mutants. The glucose phosphorylating activity of three diabetes-linked, human islet GK mutants was tested by coexpression with GLUT 2 and GLUT 3 in both intact and homogenized oocytes. Two of the GK mutants had a low level of enzymatic activity, but one GK mutant had enzymatic activity that closely resembled wild-type GK. The 3H20 production rate of the mutants 182:Val-+Met and 228:Thr-+Met, was markedly reduced compared with the wild-type GK (Fig.  4 , A and B and Table I ). In the intact oocyte assay, no GK activity was detected for either the 182:Val-Met mutant or the 228:Thr-+Met mutant. Because the GK activity is much greater in the homogenized oocyte assay (note the difference in tritiated water production between Fig. 4 A and (Table I) . Inmunoblot analysis ofGKprotein. To determine whether this reduced level of GK activity in oocytes expressing a mutant GK as compared with wild-type GK resulted from a reduced level of mutant GK protein, the amount of GK protein in a 12,000 g supernatant prepared from oocytes injected with both normal and mutant GK mRNAs was analyzed by Western blot analysis. Comparable amounts of wild-type and mutant GK protein are present in oocytes expressing GK (Fig. 5, A and B) . Coexpression of normal and mutant GK. The effect of the coexpression of a mutant and wild-type GK on the function of wild-type human islet GK was also analyzed. Table II shows that oocytes that coexpressed the wild-type human islet GK, the 228:Thr-+Met mutant, and GLUT 3 had similar kinetics properties for glucose phosphorylation as oocytes expressing the wild-type GK and GLUT 3 only. In addition, oocytes expressing wild-type GK, the 228:Thr-Met mutant, and GLUT 2 had similar levels of glucose transport and glucose phosphorylation in the intact oocyte assay as oocytes expressing wild-type GK and GLUT 2 only (Fig. 6, A and B) .
Discussion
A Xenopus oocyte system was developed to study the independent effects of glucose transporter and GK activity on glucose utilization. Oocytes contain an endogenous, high affinity HK, but glucose utilization in sham-injected oocytes is low, because glucose transport is low and rate-limiting. The expression of GLUT 2 or GLUT 3 increases transport, which results in increased glucose utilization; glucose phosphorylation then becomes the rate-limiting step. The level of glucose utilization is further increased by coexpression of either the hepatic or islet isoform of GK.
This oocyte system is a physiologically relevant model for analyzing glucose transport and phosphorylation as paired processes since both glucose transporters and GK, when expressed in oocytes, exhibit kinetic properties similar to those in tissues in which they are normally expressed. The affinity for glucose of glucose transporters expressed in oocytes is similar to the tissues in which they are normally expressed (1, 30) ; in the oocyte system, both the hepatic GK and islet GK were found to have an in situ Km for glucose similar to that found in liver and islet (references 24 and 25 and Table I ). In the beta cell, hepatocyte, and GLUT 2-or GLUT 3-expressing oocytes, glucose utilization is limited by the rate of glucose phosphorylation. This is clearly demonstrated using the oocyte system where expression of GK increases glucose utilization two-to threefold at higher glucose concentrations (5-20 mM When tested in the oocyte expression system, two diabeteslinked GK mutations exhibited a marked reduction in GK activity. One mutation, GK 182:Val-+Met, had a markedly reduced V. for glucose phosphorylation and a slight increase in the Km for glucose, whereas the GK 228:Thr--Met mutation had no detectable enzymatic activity. The amount of GK protein detected 2 d after the expression of normal and mutant GK in oocytes was similar, thus strongly suggesting that changes in protein synthesis or protein half-life are not important in altering the function of the mutant GK proteins in the beta cell and hepatocyte. The more likely mechanism, as suggested by GidhJain et al. (14) , is that the glucose or ATP binding sites of the molecule are affected. The reduced Km and V.. of these two mutants studied in oocytes were similar to those when these GK mutants were expressed in a prokaryotic system (14) .
Matschinsky and co-workers (3) have suggested that a relatively minor reduction in beta cell GK enzyme activity would 3H20 PRODUCTION (nmoUhr/oocyte)2 I_ 4,, GLUCOKINASE (Arbitrary Units)
. insulin levels as a result of the islet GK mutation and a mutation in hepatic GK protein may combine to also reduce glucose utilization in the liver. Of interest, the GK 300:Glu-+Lys mutation had a similar
Vmn and Km in the intact oocyte system and a similar V,,. and only a small increase in its Km in the oocyte homogenate assay when compared with the wild-type GK protein. Our results with this mutation differ from those reported by Gidh-Jain et al. (14) who found a Vms,, of 33% of wild-type and a higher Km for glucose (25 mM). These slight differences may relate to the expression of GK in a eukaryotic system rather than the prokaryotic system used by Gidh-Jain et al. (14) . However, both studies demonstrate that this diabetes-linked mutation possesses substantial enzymatic activity, which suggests that a reduction in glucose phosphorylation is not the etiology of the diabetes and that an alternative mechanism may be operable. This raises the possibility that some GK mutations reduce insulin secretion by a mechanism unrelated to their reduction in glucose phosphorylation. Correlation of the clinical findings (degree of hyperglycemia and insulin secretory capacity) in families with this mutation and the clinical picture in families with mutations that completely lack enzyme activity will be important. A recent report demonstrated an overall correlation of in vitro GK enzymatic activity with the insulin secretion rate in subjects with GK mutations, but one individual with a GK mutation that almost completely inactivated the enzyme in vitro had the highest insulin secretion rate (32) . The present study has established the utility of the Xenopus oocyte system to study the functional pairing of glucose transport and phosphorylation by coexpression of glucose transporters and hexokinases. The oocyte system allows for the study of a process dependent on the interaction of a transmembrane protein and a cytoplasmic protein and may be applicable to the study of other cellular processes. This system can also be used to examine glucose utilization as the level of transport and phosphorylation is varied by the amount of RNA injected and to address whether coexpression of a certain HK with a specific Fig. 1 .
transporter affects the rate of glucose utilization. In this study, we demonstrate that both glucose transporter (either GLUT 2 or GLUT 3) and GK activity are important in glucose utilization. In addition, GK is responsible for the increased glucose utilization in this system at physiologic glucose concentrations greater than 1 mM.
